Drug General Information
Drug ID	D0RE9X
Former ID	DNC007878
Drug Name	5-butyl-6-chloropyrimidine-2,4(1H,3H)-dione
Drug Type	Small molecular drug
Indication	Discovery agent		Investigative	[529120]
Structure		Download 2D MOL 3D MOL
Formula	C8H11ClN2O2
Canonical SMILES	CCCCC1=C(NC(=O)NC1=O)Cl
InChI	1S/C8H11ClN2O2/c1-2-3-4-5-6(9)10-8(13)11-7(5)12/h2-4H2,1H3,(H2,10,11,12,13)
InChIKey	CYNWJDGCUODOPW-UHFFFAOYSA-N
PubChem Compound ID	14956545
Target and Pathway
Target(s)	Thymidine phosphorylase	Target Info	Inhibitor	[529120]
BioCyc Pathway	Pyrimidine deoxyribonucleosides degradation
KEGG Pathway	Pyrimidine metabolism
	Drug metabolism - other enzymes
	Metabolic pathways
	Bladder cancer
NetPath Pathway	TSH Signaling Pathway
PathWhiz Pathway	Pyrimidine Metabolism
WikiPathways	Bladder Cancer
	Metabolism of nucleotides
	Fluoropyrimidine Activity
References
Ref 529120	J Med Chem. 2007 Nov 29;50(24):6016-23. Epub 2007 Oct 27.Discovery of 5-substituted-6-chlorouracils as efficient inhibitors of human thymidine phosphorylase.
Ref 529120	J Med Chem. 2007 Nov 29;50(24):6016-23. Epub 2007 Oct 27.Discovery of 5-substituted-6-chlorouracils as efficient inhibitors of human thymidine phosphorylase.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.